Drug connectivity mapping and functional analysis reveal therapeutic small molecules that differentially modulate myelination
Disruption or loss of oligodendrocytes (OLs) and myelin has devastating effects on CNS function and integrity, which occur in diverse neurological disorders, including Multiple Sclerosis (MS), Alzheimer’s disease and neuropsychiatric disorders. Hence, there is a need to develop new therapies that pr...
Enregistré dans:
Auteurs principaux: | A.D. Rivera, F. Pieropan, G. Williams, F. Calzolari, A.M. Butt, K. Azim |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2022
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9c39d9c18650411aa069869eba42e464 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A developmental approach to homology and brain evolution
par: ABOITIZ,FRANCISCO
Publié: (2010) -
Evolutionary Origins of the Oligodendrocyte Cell Type and Adaptive Myelination
par: Jacob H. Hines
Publié: (2021) -
“FlashMap” - A Semi-Automatic Tool for Rapid and Accurate Spatial Analysis of Marker Expression in the Subventricular Zone
par: Stefan Zweifel, et autres
Publié: (2018) -
Novel Galectin-3 Roles in Neurogenesis, Inflammation and Neurological Diseases
par: Luana C. Soares, et autres
Publié: (2021) -
Replenishing the Aged Brains: Targeting Oligodendrocytes and Myelination?
par: Xi Zhang, et autres
Publié: (2021)